Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL777786 | 0.74 | CA1 (0.35) | CA1CA2CA9CA7CA13 | |
| SCHEMBL15038058 | 0.73 | ALDH1A1 (0.36) | CA1CA2CA9 | |
| SCHEMBL1766636 | 0.71 | CA1 (0.33) | CA1CA2CA9CA7CA13 | |
| SCHEMBL778127 | 0.71 | — | — | |
| SCHEMBL14814242 | 0.69 | — | — | |
| SCHEMBL14814786 | 0.69 | — | — | |
| SCHEMBL718983 | 0.69 | TSHR (0.35) | CA1CA2CA9CA7CA13 | |
| SCHEMBL14814306 | 0.69 | CA1 (0.32) | CA1CA2CA9CA7CA13 | |
| SCHEMBL12965989 | 0.67 | — | — | |
| SCHEMBL979996 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119654742-A | Separator, secondary battery, and electricity device | 宁德时代新能源科技股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119522508-A | Separator, secondary battery, and electricity using device | 宁德时代新能源科技股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| WO-2024174068-A9 | SEPARATOR, SECONDARY BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2024-12-05 | — | — | WO | claimed |
| WO-2024174066-A9 | SEPARATOR, SECONDARY BATTERY, AND POWERED DEVICE | 宁德时代新能源科技股份有限公司 | 2024-09-26 | — | — | WO | claimed |
| WO-2024174068-A1 | SEPARATOR, SECONDARY BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2024-08-29 | — | — | WO | claimed |
| WO-2024174066-A1 | SEPARATOR, SECONDARY BATTERY, AND POWERED DEVICE | 宁德时代新能源科技股份有限公司 | 2024-08-29 | — | — | WO | claimed |
| CN-119654742-A | Separator, secondary battery, and electricity device | 宁德时代新能源科技股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119522508-A | Separator, secondary battery, and electricity using device | 宁德时代新能源科技股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| WO-2024174068-A9 | SEPARATOR, SECONDARY BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2024-12-05 | — | — | WO | disclosed |
| WO-2024174066-A9 | SEPARATOR, SECONDARY BATTERY, AND POWERED DEVICE | 宁德时代新能源科技股份有限公司 | 2024-09-26 | — | — | WO | disclosed |
| WO-2024174068-A1 | SEPARATOR, SECONDARY BATTERY, AND ELECTRIC DEVICE | 宁德时代新能源科技股份有限公司 | 2024-08-29 | — | — | WO | disclosed |
| WO-2024174066-A1 | SEPARATOR, SECONDARY BATTERY, AND POWERED DEVICE | 宁德时代新能源科技股份有限公司 | 2024-08-29 | — | — | WO | disclosed |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20150188192-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
| EP-2784074-A1 | PYRAZOLE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES | Japan Tobacco, Inc. (JP) | 2014-10-01 | — | — | EP | disclosed |
| US-8846746-B2 | Pyrazole compound and pharmaceutical use thereof | JAPAN TOBACCO INC. (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20130085132-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20120177988-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120070731-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20090325065-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | CYP2C19, CYP3A7, CYP3A5 | CA1 4140/4885CA2 1930/4885CA9 1113/4885 |
| US-20130085132-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | SLC5A1, SLC5A2, SLC34A1 | CA1 3848/4885CA2 896/4885CA9 1104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.